This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Interstitial Lung Disease
and you are
between 21 and 90
years old
Phase
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The purpose of this study is to evaluate the clinical utility of specific autoantibody testing in unmasking an underlying connective tissue disorder in patients who present with interstitial lung disease and found to have weak positive ANA (1:400 titre) with no overt connective tissue disease manifestations OR borderline/negative ANA with some clinical suggestion of connective tissue disease.
Tris trial is registered with FDA with number: NCT01600352. The sponsor of the trial is Singapore General Hospital and it is looking for 20 volunteers for the current phase.
Official trial title:
To Evaluate the Clinical Utility of Specific Autoantibody Testing in Patients With Interstitial Lung Disease